|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
|
|---|---|---|---|
| Net revenue | |||
| Cost of revenue | |||
| Gross profit | |||
| Operating expenses: | |||
| Selling expenses | |||
| General and administrative expenses | |||
| Research and development expenses | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other (loss)/ income: | |||
| Foreign currency exchange (loss)/income, net | |||
| Financial and interest income/(expenses), net | |||
| Financial and interest (loss)/income, net | |||
| Government subsidy | |||
| Other non-operating income/(expenses), net | |||
| Total other (loss)/ income | |||
| Loss before income tax expense | |||
| Income tax (expenses)/benefit | |||
| Net loss | |||
| Other comprehensive income /(loss) | |||
| Foreign currency translation adjustment | |||
| Total comprehensive loss | |||
| Loss per share | |||
| Basic (in Dollars per share) | |||
| Diluted (in Dollars per share) | |||
| Weighted average number of ordinary shares | |||
| Basic (in Shares) | |||
| Diluted (in Shares) |
Loading...